Concepedia

Douglas Weckstein

DW

Statistics

Publications

31

Citations

2.8K

H-Index

23

Active since

1983

Affiliations

Dana-Farber Cancer Institute(Current)

New Hampshire Hospital

Beth Israel Deaconess Medical Center

Massachusetts General Hospital

Memorial Sloan Kettering Cancer Center

Douglas Weckstein is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1983–2024

31

Publications

31

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2015 · 437 citations · Full text

, , +17

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Andrew L. Himelstein, Jared C. Foster, James Khatcheressian et al. · JAMA · 2017 · 357 citations · Full text

, , +17

Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401

Arti Hurria, Constance Cirrincione, Hyman B. Muss et al. · Journal of Clinical Oncology · 2011 · 347 citations · Full text

, , +15

Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer

Kimmie Ng, Halla Nimeiri, Nadine J. McCleary et al. · JAMA · 2019 · 185 citations · Full text

, , +16

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

Deborah Schrag, Hajime Uno, Rachel Rosovsky et al. · JAMA · 2023 · 141 citations · Full text

, , +17

1–5 of 31